News Details

View all news

Mirati Therapeutics to Present at the Leerink Global Healthcare Conference

1/29/2015

SAN DIEGO, Jan. 29, 2015 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX) today announced that the company will present a business overview and update at the Leerink Global Healthcare Conference on Thursday, February 12, 2015 at 8:55 a.m. Eastern Time in New York. 

A live audio webcast of the presentation will be accessible on the Investors page of the Company's website at www.mirati.com. Replays of the presentation will be available at the same location for 60 days following the conference.

About Mirati Therapeutics
Mirati Therapeutics is a targeted oncology company developing a pipeline of oncology therapeutics for precisely defined patient populations. Mirati's approach combines the three most important factors in oncology drug development - drug candidates targeting genetic and epigenetic drivers of cancer, creative and agile clinical development that selects for patients whose tumors are dependent on those driver alterations, and a highly accomplished precision medicine leadership team. The Mirati team is using a blueprint proven by their prior work for developing potential breakthrough therapies with accelerated development paths. Mirati is currently advancing three drug candidates through clinical development for multiple oncology indications. More information is available at www.mirati.com.

Company Contact:
Mirati Therapeutics Inc.
Mark J. Gergen
Executive Vice President & COO
858-332-3410

Investor Relations and Media Relations: 
Jason Spark 
Canale Communications 
619-849-6005 
jason@canalecomm.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/mirati-therapeutics-to-present-at-the-leerink-global-healthcare-conference-300025151.html

SOURCE Mirati Therapeutics, Inc.

News Provided by Acquire Media

Categories: Press Releases
View all news